Patent details

Basic Information

Publication number:

EP3331889

PCT Application Number:

US2016045104

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP167480458

PCT Publication Number:

WO2017023902

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

CYCLIC COMPOUNDS USEFUL AS MODULATORS OF TNF ALPHA

French Title of Invention:

COMPOSÉS CYCLIQUES UTILES EN TANT QUE MODULATEURS DU TNF ALPHA

German Title of Invention:

CYCLISCHE VERBINDUNGEN ALS MODULATOREN VON TNF-ALPHA

SPC Number:

Dates

Filing date:

02/08/2016

Grant date:

23/09/2020

EP Publication Date:

13/06/2018

PCT Publication Date:

09/02/2017

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

23/09/2020

EP B1 Publication Date:

23/09/2020

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

02/08/2021

Expiration date:

02/08/2036

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

16/09/2020

 

 

Name:

Bristol-Myers Squibb Company

Address:

Route 206 and Province Line Road, Princeton, NJ 08543, United States (US)

Inventor

1

Name:

DHAR, Murali T.G.

Address:

United States (US)

2

Name:

DUAN, Jingwu

Address:

United States (US)

3

Name:

XIAO, Hai-Yun

Address:

United States (US)

4

Name:

JIANG, Bin

Address:

United States (US)

Priority

Priority Number:

201562200415 P

Priority Date:

03/08/2015

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/4184; A61K 31/4188; A61P 37/00; C07D 487/04; C07D 487/14;

Publication

European Patent Bulletin

Issue number:

202039

Publication date:

23/09/2020

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages